Navigation Links
Homeless cells find temporary lodging -- and their demise
Date:11/29/2007

BOSTON, Mass. (Nov. 29, 2007)Sometimes healthy cells commit suicide. In the 1970s, scientists showed that a type of programmed cell death called apoptosis plays a key role in development, and the 2002 Nobel Prize in Physiology or Medicine recognized their work. As apoptotic cells degrade, they display standard characteristics, including irregular bulges in the membrane and nuclear fragmentation.

Now, Harvard Medical School researchers have uncovered a new type of death devoid of these features. In the Nov. 30 issue of Cell, they report a bizarre cell-in-cell invasion and death process, which they name entosis, after the Greek word for within.

We watched homeless cells, free of their normal attachments, bore into their neighbors and die inside compartments called vacuoles, says Michael Overholtzer, a postdoctoral researcher in Joan Brugges lab.

Were not sure if entosis evolved to play a particular role or if its simply an aberration of a normal process, adds Brugge, who is Chair of the Department of Cell Biology.

Overholtzer discovered entosis while working with human breast cells that normally form sheets of tissue. When these cells become detached from their protein-rich beds, they generally die through apoptosis. But Overholtzer noticed that they behave oddly long before displaying apoptotic features. In fact, many of these homeless cells actually nest inside their neighbors.

Further experimentation revealed that the cells actively invade neighboring cells. While some of the intruderswhich initially appear healthylater exit their hosts unharmed, most die inside vacuoles.

But Overholtzer didnt realize the implications of his initial observation until he crossed paths with Brigham and Womens Hospital pathologist Andrea Richardson. She informed him that the scientific literature is full of cell-in-cell references in the context of cancer.

Although these structures have been described by pathologists for decades, nobody knew how they formed, says Brugge.

Overholtzer conducted additional experiments with his non-cancerous cell line. In collaboration with Guillaume Normand of Associate Professor of Cell Biology Randall Kings lab, he tracked the cells over time and was shocked to see that some of them actively bored into their neighbors. Furthermore, the invaders appeared to be healthy.

The fate of the internalized cells was even more surprising. While most of them eventually died, some exited their hosts and swam off unharmed. Still others divided inside their vacuoles, producing daughter cellsand additional proof of the invaders viability. Overholtzer stained the suspended cells for a protein associated with apoptosis to confirm that it was not playing a role.

Pathologists have speculated for years that some internalized cells are alive and our data suggests they were right, says Overholtzer.

Next, he looked at other human cell lines. A variety of them displayed entosis when tested, including four of nine tumor lines. Cancerous MCF7 cells proved particularly prone to invasions with a whopping 30 percent of them housing neighbors. These hospitable hosts invited additional experiments.

After 24 hours, 12 percent of MCF7 cells displayed massive cellular and nuclear degradation lacking apoptotic hallmarks. All of these cells were nestled inside vacuoles, and stains implicated acidification in their death.

He still doesnt know which cell orders the killing, but it appears the houseguest forces its way into the host. The initial contacts between MCF7 cells resemble the junctions established during a normal epithelial process that occurs when cells press against each other to form dense sheets. In suspension, epithelial cells may hijack this process to push into neighboring cells or to pull the membrane of a neighboring cell around them.

The simplest explanation is that entosis is an aberration of normal epithelial processes, Overholtzer says. The invasion could occur when you get unequal contractile forces between two unanchored cells.

But he and Brugge havent ruled out other possibilities. Perhaps entosis represents a new type of programmed cell death that evolved for a particular purpose.

Its very difficult to know whether this is a cellular program with a normal role in development, says Brugge.

Regardless of its origins, entosis shows up in the clinic. Overholtzer collaborated with Edmund Cibas at Brigham and Womens Hospital and Stuart Schnitt at Beth Israel Deaconess Medical Center to obtain fluid exudates (derived from the circulatory system) and primary tumor tissue from breast cancer patients. Seven of eight exudates and 11 of 20 primary breast carcinomas displayed some cell internalization.

The next step is to determine if entosis helps or hurts cancer cells.

Our first instinct is that entosis inhibits tumor progression by killing homeless cancer cells before they colonize distant sites, and were working on ways to model this, says Overholtzer. One could also imagine that entosis promotes tumor progression by providing nutrients for some cells from their neighbors, but we do not yet have evidence for this.


'/>"/>

Contact: Alyssa Kneller
public_affairs@hms.harvard.edu
617-432-0442
Harvard Medical School
Source:Eurekalert

Related medicine news :

1. $8,000 Winning Bids at Governors Livestock Auction to Benefit College-Bound Youth and Homeless
2. United Way of Greater Los Angeles Kicks Off Initiative to Prevent and End Homelessness With HomeWalk 2007
3. The Jericho Project Announces Rehabilitation Residence for Homeless and Low-Income Veterans
4. Homeless Vets - VA Sets the Record Straight
5. New Gallup Survey Finds Half of Los Angeles Area Residents Have Taken in a Near-Homeless Person, One-Third Fear Homelessness Themselves
6. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
7. Brain cells work differently than previously thought
8. Embryonic Stem Cells Repair Human Heart
9. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
10. Circulating fats kill transplanted pancreas cells, study shows
11. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
Breaking Medicine Technology: